Gammagard Liquid FDA Approval History
FDA Approved: Yes (First approved May 2, 2005)
Brand name: Gammagard Liquid
Generic name: immune globulin infusion (human)
Dosage form: Solution
Company: Baxter Healthcare Corporation
Treatment for: Primary Immunodeficiency Syndrome
Gammagard (immune globulin infusion (human)) is an immune globulin infusion (human) indicated as replacement therapy for primary humoral immunodeficiency (PI) in adult and pediatric patients two years of age or older.
Development Timeline for Gammagard Liquid
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.